An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
No abstract
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2022-02-01
|
Series: | Počki |
Online Access: | https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/357 |